Jesse Boehm
@boehmjesse
Followers
2K
Following
127
Media
77
Statuses
2K
Chief Science Officer, Break Through Cancer; Principal Investigator: https://t.co/XI1QrUIt95 @ Koch Institute, MIT
Cambridge, MA
Joined September 2012
RT @DTRFoundation: There is an increased need for fresh desmoid tumor tissue samples for research. If you have a desmoid patient considerin….
0
2
0
RT @AACR: Benjamin D. Hopkins, Jesse S. Boehm, and Peter Horak discussed "Functional and Genomic Precision Medicine in Solid Tumors" in a p….
0
1
0
RT @break_cancer: This #InternationalWomensDay we’re spotlighting some of the women leading the charge in cancer research that we are proud….
0
3
0
RT @break_cancer: Dr. Nilofer Azad’s (@hopkinskimmel) work combining targeted and immunotherapies as well as cancer vaccines is shaping the….
0
2
0
RT @break_cancer: Dr. Stephanie Dougan’s (@DanaFarber) is advancing immunotherapy with our Conquering KRAS and Demystifying Pancreatic Canc….
0
1
0
RT @break_cancer: Dr. Zuzana Tothova (@DanaFarber) is uncovering how epigenetic changes drive clonal hematopoiesis and myeloid malignancies….
0
1
0
RT @break_cancer: Dr. Natalie Vokes (@NIVokes, @MDAndersonNews) is using cancer genomics to uncover predictors of therapy response and resi….
0
2
0
RT @break_cancer: Dr. Adrienne Boire (@MSKCancerCenter) studies how cancer adapts to the leptomeningeal space and using spinal fluid to bet….
0
1
0
RT @break_cancer: Dr. Duaa Al-Rawi (@MSKCancerCenter) is detecting and modeling early invasive ovarian cancer, by studying serous tubal int….
0
1
0
RT @break_cancer: Dr. Paula Hammond’s (@kochinstitute) groundbreaking work in nanotechnology has transformed drug delivery and materials sc….
0
1
0
RT @break_cancer: Dr. Jacqueline S. Garcia (@DanaFarber) is finding vulnerabilities in resistant AML to better understand targeted therapie….
0
1
0
RT @break_cancer: Dr. Linghua Wang (@IamLinghua, @MDAndersonNews) leads a computational biology lab, using single-cell and spatial omics to….
0
4
0
RT @IamLinghua: Deeply grateful for the support from @break_cancer and for being included in this #InternationalWomensDay spotlight! I’m pr….
0
2
0
RT @break_cancer: Today our CSO, @boehmjesse, joins the “From Bench to Bedside: Rare Cancer Innovations” panel at @BostonGlobe Rare Disease….
0
1
0
RT @break_cancer: Our CSO, @boehmjesse, delivers the closing keynote at #slas2025 today—reflecting on a decade of lab science innovation, t….
0
2
0
RT @break_cancer: We are excited to have launched an expanded Phase 1 trial cohort for pancreatic cancer with Revolution Medicines. This tr….
0
4
0
RT @SchenkLab: Thrilled to be part of the Lung TeamLab and the incredible collaboration to eliminate residual disease!.
0
2
0
RT @vincentlamMD: Honored to be part of this #radicalcollaboration to advance cures in ALK+ and other lung cancers. Let's go!! @break_cance….
0
5
0
RT @christine_lovly: Tackling big problems requires radical collaboration 💪. The “PoweRD 2 Cure” team strives to overcome minimal residual….
0
10
0
RT @ALKPositiveinc: Our vision is a world in which ALK+ cancer is a curable disease. Proud to be supporters of @break_cancer’s bold initiat….
0
6
0